105 related articles for article (PubMed ID: 9794346)
1. Effectiveness of three different doses of carvedilol for exertional angina. Carvedilol-Angina Study Group.
Weiss R; Ferry D; Pickering E; Smith LK; Dennish G; Krug-Gourley S; Lukas MA
Am J Cardiol; 1998 Oct; 82(8):927-31. PubMed ID: 9794346
[TBL] [Abstract][Full Text] [Related]
2. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris.
van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A
Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r.
van der Does R; Eberhardt R; Derr I; Ehmer B; Rudorf J; Uberbacher HJ
Eur Heart J; 1991 Jan; 12(1):60-4. PubMed ID: 2009895
[TBL] [Abstract][Full Text] [Related]
4. Carvedilol versus verapamil in chronic stable angina: a multicentre trial.
Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E
Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677
[TBL] [Abstract][Full Text] [Related]
5. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris.
Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB
Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina.
van der Does R; Eberhardt R; Derr I; Ehmer B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
[TBL] [Abstract][Full Text] [Related]
9. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Sellier P; Broustet JP
Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
[TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
[TBL] [Abstract][Full Text] [Related]
11. The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol.
Basu S; Senior R; Raftery EB; Lahiri A
Eur Heart J; 1996 Dec; 17 Suppl F():43-7. PubMed ID: 8960447
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of carvedilol (BM 14,190), a new beta-blocking drug with vasodilating properties, in exercise-induced ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
Am J Cardiol; 1985 Jul; 56(1):35-40. PubMed ID: 2861738
[TBL] [Abstract][Full Text] [Related]
13. Vasodilating beta-blockers in heart failure.
Raftery EB
Eur Heart J; 1995 Jul; 16 Suppl F():32-7. PubMed ID: 8521882
[TBL] [Abstract][Full Text] [Related]
14. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study.
Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK
Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556
[TBL] [Abstract][Full Text] [Related]
15. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
Nahrendorf W; Rading A; Steinig G; van der Does R; Schlote A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S114-6. PubMed ID: 1378136
[TBL] [Abstract][Full Text] [Related]
16. Comparison of carvedilol and atenolol for angina pectoris.
Freedman SB; Jamal SM; Harris PJ; Kelly DT
Am J Cardiol; 1987 Sep; 60(7):499-502. PubMed ID: 2888302
[TBL] [Abstract][Full Text] [Related]
17. [Clinical and hemodynamic effects of anaprilin and carvedilol in patients with coronary heart disease].
Vasil'ev AP; Strel'tsova NN; Gorbunova TIu; Dubova TV
Klin Med (Mosk); 2001; 79(12):13-6. PubMed ID: 11840802
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of carvedilol in exercise-induced myocardial ischemia.
Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360
[TBL] [Abstract][Full Text] [Related]
19. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
Glasser SP
Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
[TBL] [Abstract][Full Text] [Related]
20. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action.
Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]